RushNet, Inc. (OTCPK:RSHN) acquired Cal City Concentrates on April 30, 2019. Only a very small portion of the acquisition costs have been paid in advance and the balance of the payments are deferred. In related transactions RushNet acquired Bella Buds and Investment Partner Holdings LLC. The transaction was funded by the principals of RushNet and XYZ Hemp Inc., the company having significant profit participation in RushNet Inc.’s acquisitions.
RushNet, Inc. (OTCPK:RSHN) completed the acquisition of Cal City Concentrates on April 30, 2019.
RushNet, Inc. operates under the name HeliosDX. HeliosDX is a national clinical reference laboratory offering high-complexity urine drug testing (UDT), behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease (PCR). The Company provides management services and insurance billing services principally to clinical reference laboratories. It provides PGX testing through Leo Partners. It provides oral fluid toxicology testing for a range of drugs. The Quantisal Collection Procedure makes taking the sample quick and easy. HeliosDX also offers a preliminary 10-panel plus adulteration detection screen, as well as confirmation testing via its comprehensive toxicology panel. Its subsidiaries include Chattahoochee Physicians Laboratory Services, LLC; doing business as HeliosDx and Grandeza Healthcare Consultants, LLC.
RUSHNET, INC. 